Gain Therapeutics Presents New Preclinical Data Showing Promising Pharmacological Activity in Parkinson's Disease Patient-Derived Dopaminergic Neurons

Gain Therapeutics Presents New Preclinical Data Showing Promising Pharmacological Activity in Parkinson’s Disease Patient-Derived Dopaminergic Neurons - read this article along with other careers information, tips and advice on BioSpace

Related Keywords

Matthias Alder ,Stacey Jurchison ,European Union Horizon ,Gain Therapeutics Inc ,Shaare Zedek Medical Center Gba Parkinson Disease Symposium ,Nasdaq ,Company Annual Report On Form ,Exchange Commission ,Silverstein Foundation For Parkinson ,Michaelj Fox Foundation For Parkinson Research ,Shaare Zedek Medical Center ,Disease Modifying Potential ,Disease Symposium ,Structurally Targeted Allosteric Regulator ,Manolo Bellotto ,Chief Strategy Officer ,General Manager ,Gain Therapeutics ,Chief Executive Officer ,Gaucher Disease ,Silverstein Foundation ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,Current Reports ,Media Contact ,Resume ,Careers ,Ain Therapeutics Presents New Preclinical Data Showing Promising Pharmacological Activity In Parkinsons Disease Patient Derived Dopaminergic Neurons ,Iospace ,Advice ,